Oral film compositions and dosage forms having precise active dissolution profiles
US12290597B2 · kind B2 · utility
0Cited by
38References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2022 |
| Grant date | May 6, 2025 |
| Priority date | — |
| Expiry date | Dec 30, 2042 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral film in an individual unit dose for delivery of one or more actives is disclosed herein, the film having a precisely calculated and controlled active dissolution profile. A wide variety of actives may be used, including, for example, clobazam, diazepam, or riluzole. Also disclosed are methods of treating a variety of diseases and conditions, for example, epilepsy and seizures, by administering the oral film disclosed herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.